Bibliographic Details
| Title: |
Clade II Mpox Surveillance Update -- United States, October 2023-April 2024. |
| Authors: |
Tuttle, Alexandra, Hughes, Christine M., Dvorak, Mitchell, Aeschleman, Leah, Davidson, Whitni, Wilkins, Kimberly, Gigante, Crystal, Satheshkumar, Panayampalli S., Rao, Agam K., Minhaj, Faisal S., Christensen, Bryan E., McQuiston, Jennifer H., Hutson, Christina L., McCollum, Andrea M. |
| Source: |
MMWR: Morbidity & Mortality Weekly Report; 5/23/2024, Vol. 73 Issue 20, p474-476, 3p |
| Subject Terms: |
VIRUSES, HOSPITAL care, VACCINATION, DISEASE outbreaks |
| Geographic Terms: |
UNITED States |
| Abstract: |
The article provides an update on the surveillance of Clade II Monkeypox virus (MPXV) in the United States from October 2023 to April 2024, detailing the reported cases, demographics, hospitalizations, vaccination status, and transmission trends. It states that despite a significant reduction in cases compared to the peak outbreak in 2022, MPXV transmission continues at low levels, with a focus on genomic sequencing and clade-specific testing. |
| Database: |
Complementary Index |
